Atlanta-based Brain Tumor Foundation for Children received funds, which will help children and their families
ATLANTA, GA United States — Wednesday, September 25, 2013
Elekta activities at the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO) raised a total of $67,000 for the Brain Tumor Foundation for Children (BTFC), the first nonprofit organization in the United States to focus on pediatric brain tumor disease. The BTFC provides financial assistance, social support and information to families of children with brain and spinal cord tumors; funds research projects that improve treatment options and the search for a cure; as well as raises public awareness of the disease and advocates on behalf of children who are affected.
“We are incredibly grateful and honored to be featured as the Elekta’s benefit charity for this year,” says Mary Moore, Executive Director of BTFC. “The proceeds are going to help us assist the families of children with brain tumors with emergency financial needs while their child is on treatment.”
The donation came from proceeds from ticket sales and a silent auction for Elekta’s Charity Splash, held Saturday, September 21 at the Georgia Aquarium, where more than 1,000 attendees enjoyed live music and dancing. The night was especially meaningful to an important guest Moore invited, 17-year-old Braden Pilcher, who was diagnosed with a glioblastoma – an aggressive, malignant primary brain tumor – when he was four-years-old. This was Braden’s first visit to the Georgia Aquarium.
“He has suffered every imaginable difficulty going through all of this over the years,” she says. “Braden will be celebrating his 18th birthday on October 2, so we wanted to acknowledge his courage and determination.”
“Organizations such as the Brain Tumor Foundation for Children are part of an absolutely vital support network for families who are touched by this disease,” adds Jay Hoey, Executive Vice President, Elekta. “We are proud to use the occasion of our annual charitable event to ensure BTFC and its sister institutions carry on their important activities.”
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.